"In their own words": delineating the contours of dyspnea invisibility in patients with advanced chronic obstructive pulmonary disease from quantitative discourse analysis.

Breathlessness Chronic obstructive pulmonary disease Dyspnea Dyspnea invisibility Integrative medicine Lexicometry Pulmonary rehabilitation

Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
04 Jan 2024
Historique:
received: 20 08 2023
accepted: 25 12 2023
medline: 5 1 2024
pubmed: 5 1 2024
entrez: 4 1 2024
Statut: epublish

Résumé

Dyspnea conveys an upsetting or distressing experience of breathing awareness. It heavily weighs on chronic respiratory disease patients, particularly when it persists despite maximal treatment of causative abnormalities. The physical, psychological and social impacts of persistent dyspnea are ill-appreciated by others. This invisibility constitutes a social barrier and impedes access to care. This study aimed to better understand dyspnea invisibility in patients with chronic obstructive pulmonary disease (COPD) through quantitative discourse analysis. We conducted a lexicometric analysis (lemmatization, descending hierarchical classification, multicomponent analysis, similarity analysis) of 11 patients' discourses (6 men, severe COPD; immediate postexacerbation rehabilitation) to identify semantic classes and communities, which we then confronted with themes previously identified using interpretative phenomenological analysis (IPA). Class#1 ("experience and need for better understanding"; 38.9% of semantic forms, 50% of patients) illustrates the gap that patients perceive between their experience and what others see, confirming the importance of dyspnea invisibility in patients' concerns. Class#2 ("limitations"; 28.7% of forms) and Class#3 (management"; 13.1% of forms) point to the weight of daily limitations in performing basic activities, of the need to accept or adapt to the constraints of the disease. These three classes matched previously identified IPA-derived themes. Class#4 ("hospitalization"; 18.2% of forms) points to the importance of interactions with the hospital, especially during exacerbations, which constitutes novel information. Lexicometry confirms the importance of dyspnea invisibility as a burden to COPD patients.

Sections du résumé

BACKGROUND BACKGROUND
Dyspnea conveys an upsetting or distressing experience of breathing awareness. It heavily weighs on chronic respiratory disease patients, particularly when it persists despite maximal treatment of causative abnormalities. The physical, psychological and social impacts of persistent dyspnea are ill-appreciated by others. This invisibility constitutes a social barrier and impedes access to care. This study aimed to better understand dyspnea invisibility in patients with chronic obstructive pulmonary disease (COPD) through quantitative discourse analysis.
METHODS METHODS
We conducted a lexicometric analysis (lemmatization, descending hierarchical classification, multicomponent analysis, similarity analysis) of 11 patients' discourses (6 men, severe COPD; immediate postexacerbation rehabilitation) to identify semantic classes and communities, which we then confronted with themes previously identified using interpretative phenomenological analysis (IPA).
RESULTS RESULTS
Class#1 ("experience and need for better understanding"; 38.9% of semantic forms, 50% of patients) illustrates the gap that patients perceive between their experience and what others see, confirming the importance of dyspnea invisibility in patients' concerns. Class#2 ("limitations"; 28.7% of forms) and Class#3 (management"; 13.1% of forms) point to the weight of daily limitations in performing basic activities, of the need to accept or adapt to the constraints of the disease. These three classes matched previously identified IPA-derived themes. Class#4 ("hospitalization"; 18.2% of forms) points to the importance of interactions with the hospital, especially during exacerbations, which constitutes novel information.
CONCLUSIONS CONCLUSIONS
Lexicometry confirms the importance of dyspnea invisibility as a burden to COPD patients.

Identifiants

pubmed: 38178139
doi: 10.1186/s12931-023-02655-4
pii: 10.1186/s12931-023-02655-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21

Informations de copyright

© 2024. The Author(s).

Références

Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435–52.
doi: 10.1164/rccm.201111-2042ST pubmed: 22336677 pmcid: 5448624
Carel H, Macnaughton J, Dodd J. Invisible suffering: breathlessness in and beyond the clinic. Lancet Respir Med. 2015;3:278–9.
doi: 10.1016/S2213-2600(15)00115-0 pubmed: 25890648
Carel H: Invisible suffering: the experience of breathlessness. In: Atmospheres of Breathing. Skof L, Berndtson P eds., Albany (NY); 2018: Wellcome Trust-Funded Monographs and Book Chapters].
Johnson MJ, Yorke J, Hansen-Flaschen J, Lansing R, Ekstrom M, Similowski T, Currow DC. Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J. 2017;49:1602277.
doi: 10.1183/13993003.02277-2016 pubmed: 28546269
Morelot-Panzini C, Adler D, Aguilaniu B, Allard E, Bautin N, Beaumont M, Blanc FX, Chenivesse C, Dangers L, Delclaux C, et al. Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic. Eur Respir J. 2017;50:1701297.
doi: 10.1183/13993003.01159-2017
van der Meide H, Teunissen T, Visser LH, Visse M. Trapped in my lungs and fighting a losing battle. A phenomenological study of patients living with chronic obstructive and pulmonary disease. Scand J Caring Sci. 2020;34:118–27.
doi: 10.1111/scs.12713 pubmed: 31099083
Harrison SL, Robertson N, Apps L. M CS, Morgan MD, Singh SJ: “We are not worthy”–understanding why patients decline pulmonary rehabilitation following an acute exacerbation of COPD. Disabil Rehabil. 2015;37:750–6.
doi: 10.3109/09638288.2014.939770 pubmed: 25009949
Suen AO, Iyer AS, Cenzer I, Farrand E, White DB, Singer J, Sudore R, Kotwal A: National prevalence of social isolation and loneliness in adults with chronic obstructive pulmonary disease. Ann Am Thorac Soc 2023.
Banzett RBB, Sheridan AR, Baker KM, Lansing RW, Stevens JP. “Scared to death” dyspnoea from the hospitalised patient’s perspective. BMJ Open Respir Res. 2020;7: e000493.
doi: 10.1136/bmjresp-2019-000493 pubmed: 32169831 pmcid: 7069254
Gysels M, Higginson IJ. Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness. J Pain Symp Manag. 2008;36:451–60.
doi: 10.1016/j.jpainsymman.2007.11.008
Kochovska S, Chang S, Ferreira D, Brunelli VN, Luckett T, Morgan L, Johnson MJ, Ekstrom M, Currow DC. Invisibility of breathlessness in clinical consultations: a cross-sectional, national online survey. Eur Respir J. 2022;60:2201603.
doi: 10.1183/13993003.01603-2022 pubmed: 36202418
Basoglu M. Effective management of breathlessness: a review of potential human rights issues. Eur Respir J. 2017;49:1602099.
doi: 10.1183/13993003.02099-2016 pubmed: 28546267
Serresse L, Guerder A, Dedonder J, Nion N, Lavault S, Morelot-Panzini C, Gonzalez-Bermejo J, Benoit L, Similowski T. “You can’t feel what we feel”: Multifaceted dyspnoea invisibility in advanced chronic obstructive pulmonary disease examined through interpretative phenomenological analysis. Palliat Med. 2022;36:1364–73.
doi: 10.1177/02692163221118198 pubmed: 36154535
Biggerstaff D, Thompson A. Interpretative phenomenological analysis (IPA): a qualitative methodology of choice in healthcare research. Qual Res Psychol. 2008;5:214–24.
doi: 10.1080/14780880802314304
Montalescot L, Rascle N, Combe C, Untas A. Patients’ experience one year after dialysis initiation: a lexicometric analysis. Health Psychol Behav Med. 2021;9:380–97.
doi: 10.1080/21642850.2021.1918552 pubmed: 34104566 pmcid: 8158193
Global initiative for chronic obstructive lung disease: 2021 GOLD reports. https://gold.copd.org/2021-gold-reports/ .
Scholz R. Lexicometry: a quantifying heuristic for social scientists in discourse studies. In: Scholz R, editor. Quantifying Approaches to discourse for social scientists. Cham: Springer International Publishing; 2019. p. 123–53.
doi: 10.1007/978-3-319-97370-8_5
Lebart L, Salem A, Berry L. Exploring textual data. Berlin: Springer Science & Business Media; 1997.
Reinert A. Une méthode de classification descendante hiérarchique: application à l’analyse lexicale par contexte. Cahiers de l’analyse des données. 1983;8:187–98.
Reinert M. Les mondes lexicaux et leur logique à travers l’analyse statistique d’un corpus de récits de cauchemars. Lang Soc. 1993;66:5–39.
doi: 10.3406/lsoc.1993.2632
Noel-Jorand MC, Reinert M, Giudicelli S, Dassa D. A new approach to discourse analysis in psychiatry, applied to a schizophrenic patient’s speech. Schizophr Res. 1997;25:183–98.
doi: 10.1016/S0920-9964(97)00022-4 pubmed: 9264174
Newman M. Modularity and community structure in networks. Proc Natl Acad Sci. 2006;103:8577–696.
doi: 10.1073/pnas.0601602103 pubmed: 16723398 pmcid: 1482622
Blondel VD, Guillaume JL, Lambiotte R, Lefebvre E. Fast unfolding of communities in large networks. J Stat Mech. 2008;10:1008.
Denzin NK. The research act. Chicago: Aldine; 1970.
Golafshani N. Understanding reliability and validity in qualitative research. Qual Rep. 2003;8:597–606.
Lauri MA. Triangulation of data analysis techniques. Papers Soc Represent. 2011;20:34.31-34.15.
Ferreira DH, Kochovska S, Honson A, Phillips JL, Currow DC. Two faces of the same coin: a qualitative study of patients’ and carers’ coexistence with chronic breathlessness associated with chronic obstructive pulmonary disease (COPD). BMC Palliat Care. 2020;19:64.
doi: 10.1186/s12904-020-00572-7 pubmed: 32375747 pmcid: 7203967
Sigurgeirsdottir J, Halldorsdottir S, Arnardottir RH, Gudmundsson G, Bjornsson EH. COPD patients’ experiences, self-reported needs, and needs-driven strategies to cope with self-management. Int J Chron Obstruct Pulmon Dis. 2019;14:1033–43.
doi: 10.2147/COPD.S201068 pubmed: 31190788 pmcid: 6529673
Tavares N, Hunt KJ, Jarrett N, Wilkinson TM. The preferences of patients with chronic obstructive pulmonary disease are to discuss palliative care plans with familiar respiratory clinicians, but to delay conversations until their condition deteriorates: a study guided by interpretative phenomenological analysis. Palliat Med. 2020;34:1361–73.
doi: 10.1177/0269216320937981 pubmed: 32720555
Breaden K, Collier A, Litster C, Allcroft P, Currow DC, Phillips JL. Stigma and the in(visible) perspectives and expectations of home oxygen therapy among people with chronic breathlessness syndrome: a qualitative study. Palliat Med. 2019;33:82–90.
doi: 10.1177/0269216318805621 pubmed: 30296930
Bucci F, Vanheule S. Families of adult people with disability: Their experience in the use of services run by social cooperatives in Italy. Int J Soc Welf. 2018;27:157–67.
doi: 10.1111/ijsw.12283
Denoual H, Dargentas M, Roudaut S, Balez R, Sizun J. Father’s role in supporting breastfeeding of preterm infants in the neonatal intensive care unit: a qualitative study. BMJ Open. 2016;6: e010470.
doi: 10.1136/bmjopen-2015-010470 pubmed: 27338878 pmcid: 4932310
Courvoisier N, Storari C, Lesage S, Vittoz L, Barbieux C, Peytremann-Bridevaux I, Gilles I, Calmy A. Facilitators and barriers of women’s participation in HIV clinical research in Switzerland: a qualitative study. HIV Med. 2022;23:441–7.
doi: 10.1111/hiv.13259 pubmed: 35178844 pmcid: 9305145
Calcagni N, Venier AG, Nasso R, Broc G, Ardichen E, Jarrige B, Parneix P, Quintard B. Barriers and facilitators on hand hygiene and hydro-alcoholic solutions’ use: representations of health professionals and prevention perspectives. Infect Prev Pract. 2021;3: 100169.
doi: 10.1016/j.infpip.2021.100169 pubmed: 34522880 pmcid: 8426555
Guzmán-Osorio GM, Chávez-Vallejo SL, Monzerrat Silvat G, Parrello S, Ioro I. Partners of patients with a chronic disease. Narrative enquiry of hemophilia. Rev Electrón Psicol Iztacala. 2017;20:548–69.
Lelorain S, Tessier P, Florin A, Bonnaud-Antignac A. Posttraumatic growth in long term breast cancer survivors: relation to coping, social support and cognitive processing. J Health Psychol. 2012;17:627–39.
doi: 10.1177/1359105311427475 pubmed: 22100393
Moscato A, Varescon I. Satisfaction and difficulties of French professional home caregivers in supporting older people with Alzheimer’s disease or alcohol misuse. Health Soc Care Commun. 2018;26:27–34.
doi: 10.1111/hsc.12457
Trifu RN, Nemes B, Bodea-Hategan C, Cozman D. Linguistic indicators of language in major depressive disorder : an evidence-based research. J Evid Based Psychother. 2017;17:105–28.
doi: 10.24193/jebp.2017.1.7
Makanikas K, Andreou G, Vlachos F. Chronic obstructive pulmonary disease and semantic language abilities. J Behav Brain Sci. 2019;9:130–43.
doi: 10.4236/jbbs.2019.93011
Teixeira PJ, Porto L, Kristensen CH, Santos AH, Menna-Barreto SS, Do Prado-Lima PA. Post-traumatic stress symptoms and exacerbations in COPD patients. COPD. 2015;12:90–5.
doi: 10.3109/15412555.2014.922063 pubmed: 24983958
Habraken JM, Pols J, Bindels PJ, Willems DL. The silence of patients with end-stage COPD: a qualitative study. Br J Gen Pract. 2008;58:844–9.
doi: 10.3399/bjgp08X376186 pubmed: 19068157 pmcid: 2593533
Abe T, Nishiyama J, Kushida S, Kawashima M, Oishi N, Ueda K. Tailored opening questions to the context of using medical questionnaires: qualitative analysis in first-visit consultations. J Gen Fam Med. 2023;24:79–86.
doi: 10.1002/jgf2.593 pubmed: 36909788
Malpass A, McGuire C, Macnaughton J. “The body says it”: the difficulty of measuring and communicating sensations of breathlessness. Med Humanit. 2022;48:63–75.
doi: 10.1136/medhum-2019-011816 pubmed: 33509802

Auteurs

Jonathan Dedonder (J)

Institute for the Analysis of Change in Contemporary and Historical Societies (IACS), Université Catholique de Louvain, Louvain-La-Neuve, Belgique.

Christelle Gelgon (C)

Unité Mobile d'accompagnement et de Soins Palliatifs, AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Fédération "Soins Palliatifs, Accompagnement et Soins de Support", AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Hôpital Pitié-Salpêtrière, 47-83 Bd de l'Hôpital, 75651, Paris Cedex 13, France.

Antoine Guerder (A)

Service de Médecine de Réadaptation Respiratoire, Département R3S, AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Hôpital Pitié-Salpêtrière, 75013, Paris, France.

Nathalie Nion (N)

Département R3S, AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, 75005, Paris, France.

Sophie Lavault (S)

Service de Pneumologie, Département R3S, AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Hôpital Pitié-Salpêtrière, 75013, Paris, France.

Capucine Morélot-Panzini (C)

Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, 75005, Paris, France.
Service de Pneumologie, Département R3S, AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Hôpital Pitié-Salpêtrière, 75013, Paris, France.

Jésus Gonzalez-Bermejo (J)

Service de Médecine de Réadaptation Respiratoire, Département R3S, AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, 75005, Paris, France.

Laelia Benoit (L)

Child Study Center, QUALab Qualitative and Mixed Methods Lab, Yale School of Medicine, New Haven, CT, USA.
Inserm U1018, Team DevPsy, Maison de Solenn, Hôpital Cochin, AP-HP, Paris, France.

Thomas Similowski (T)

Département R3S, AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, 75005, Paris, France.

Laure Serresse (L)

Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, 75005, Paris, France. laure.serresse@aphp.fr.
Fédération "Soins Palliatifs, Accompagnement et Soins de Support", AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Hôpital Pitié-Salpêtrière, 47-83 Bd de l'Hôpital, 75651, Paris Cedex 13, France. laure.serresse@aphp.fr.

Classifications MeSH